IL156045A0 - Compositions containing gangliosides for use in the treatment of skin disorders - Google Patents

Compositions containing gangliosides for use in the treatment of skin disorders

Info

Publication number
IL156045A0
IL156045A0 IL15604501A IL15604501A IL156045A0 IL 156045 A0 IL156045 A0 IL 156045A0 IL 15604501 A IL15604501 A IL 15604501A IL 15604501 A IL15604501 A IL 15604501A IL 156045 A0 IL156045 A0 IL 156045A0
Authority
IL
Israel
Prior art keywords
treatment
compositions containing
skin disorders
containing gangliosides
gangliosides
Prior art date
Application number
IL15604501A
Other languages
English (en)
Original Assignee
Childrens Memorial Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Memorial Hospital filed Critical Childrens Memorial Hospital
Publication of IL156045A0 publication Critical patent/IL156045A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL15604501A 2000-12-08 2001-12-07 Compositions containing gangliosides for use in the treatment of skin disorders IL156045A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25438700P 2000-12-08 2000-12-08
US10/013,788 US20020122795A1 (en) 2000-12-08 2001-12-07 Compositions containing gangliosides for use in the treatment of skin disorders
PCT/US2001/047551 WO2002045740A1 (en) 2000-12-08 2001-12-07 Compositions containing gangliosides for use in the treatment of skin disorders

Publications (1)

Publication Number Publication Date
IL156045A0 true IL156045A0 (en) 2003-12-23

Family

ID=26685246

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15604501A IL156045A0 (en) 2000-12-08 2001-12-07 Compositions containing gangliosides for use in the treatment of skin disorders

Country Status (7)

Country Link
US (1) US20020122795A1 (ja)
EP (1) EP1349567A4 (ja)
JP (1) JP2004531469A (ja)
AU (1) AU2002226060A1 (ja)
GB (1) GB2388777A (ja)
IL (1) IL156045A0 (ja)
WO (1) WO2002045740A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998392B2 (en) 2003-04-02 2006-02-14 Mti Meta Tech Inc. Formulation to treat or prevent parasitic infection
US7851451B2 (en) 2004-03-12 2010-12-14 Mti Meta Tech Inc. Formulations for mediating inflammatory bowel disorders
US8536140B2 (en) 2004-03-12 2013-09-17 Mti Meta Tech Inc. Methods for treating inflammatory bowel disease
JPWO2006028241A1 (ja) * 2004-09-08 2008-05-08 武田薬品工業株式会社 動脈硬化の予防・治療用医薬
JP2008214241A (ja) * 2007-03-02 2008-09-18 Snow Brand Milk Prod Co Ltd 免疫調節剤
JP5596444B2 (ja) * 2010-07-07 2014-09-24 花王株式会社 抗炎症剤の評価又は選択方法
US20130040953A1 (en) * 2011-08-10 2013-02-14 Amy S. Paller Promotion of wound healing
US9655967B2 (en) * 2011-12-09 2017-05-23 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of focal adhesion kinase for control of scar tissue formation
JP7312993B2 (ja) * 2020-05-25 2023-07-24 静岡県公立大学法人 エラスチン産生促進剤及び皮膚化粧料

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA833446B (en) * 1982-05-28 1984-02-29 Solco Basel Ag Process for the preparation of cell-and tissue-regenerating substances
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
US4767746A (en) * 1985-12-04 1988-08-30 Trustees Of Boston University Method for enhancement of healing of epithelial wounds in mammals
GB8620361D0 (en) * 1986-08-21 1986-10-01 Windleshaw Enterprises Ltd Pharmaceutical compositions
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
US5272138A (en) * 1988-02-12 1993-12-21 The Biomembrane Institute Naturally occurring gangliosides containing de-N-acetyl-sialic acid and their applications as modifiers of cell physiology
US5102663A (en) * 1988-10-18 1992-04-07 Sloan-Kettering Instutute For Cancer Research Vaccine for stimulating or enhancing production of antibodies against 9-O-acetyl GD3
US5840317A (en) * 1989-11-03 1998-11-24 Morton; Donald L. Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen
DE4107154A1 (de) * 1990-10-11 1992-04-16 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen melanom
US5208146A (en) * 1990-11-05 1993-05-04 The Regents Of The University Of California Murine monoclonal anti-idiotype antibodies
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
WO1993010221A1 (en) * 1991-11-13 1993-05-27 The Regents Of The University Of California Chimeric murine/human anti-idiotype monoclonal antibodies
DE4208795A1 (de) * 1992-03-19 1993-09-23 Behringwerke Ag Monoklonaler anti-gangliosid-antikoerper, seine herstellung und verwendung als tumortherapeutikum
WO1994000127A1 (en) * 1992-06-19 1994-01-06 The Regents Of The University Of California Lipids for epidermal moisturization and repair of barrier function
DE69328435T2 (de) * 1992-10-22 2000-09-14 Kirin Brewery Neues sphingolglycolipid und verwendung davon
JP3141693B2 (ja) * 1994-08-16 2001-03-05 ダイキン工業株式会社 シアル酸の９位をフッ素で置換したガングリオシドｇｍ３類縁体及びその中間体
US6054433A (en) * 1994-11-03 2000-04-25 The Regents Of The University Of California Methods and compositions for stimulating tissue growth and epithelial moisturization
US5977316A (en) * 1995-01-17 1999-11-02 The Board Of Trustees Of The University Of Kentucky Monoclonal antibody 1A7 and related polypeptides
CA2227013A1 (en) * 1995-07-14 1997-02-06 Glycotech Corp. Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
US5690966A (en) * 1996-10-17 1997-11-25 Council Of Scientific & Industrial Research Process for the preparation of an extract from human placenta containing glycosphingolipids and endothelin-like constituent peptides useful for the treatment of vitiligo
WO1998039027A2 (en) * 1997-03-05 1998-09-11 John Wayne Cancer Institute Sialyl lewis antigens as targets for immunotherapy
CU22731A1 (es) * 1998-02-05 2002-02-28 Centro Inmunologia Molecular Anticuerpo monoclonal que reconoce el oligosacárido ácido siálico n´glicolilado-galactosa-glucosa (ngcneu-gal-glu) en tumores malignos y composiciones farmacéuticas que los contienen

Also Published As

Publication number Publication date
JP2004531469A (ja) 2004-10-14
GB0316026D0 (en) 2003-08-13
GB2388777A (en) 2003-11-26
EP1349567A1 (en) 2003-10-08
EP1349567A4 (en) 2005-10-12
WO2002045740A1 (en) 2002-06-13
AU2002226060A1 (en) 2002-06-18
US20020122795A1 (en) 2002-09-05

Similar Documents

Publication Publication Date Title
IL127943A (en) Pharmaceutical and cosmetic compositions for the treatment of skin disorders
PL351328A1 (en) Liquid compositions containing an agent beneficial for human skin
HUP0400529A3 (en) Use of chlorpromazine and pentamidine for preparation of pharmaceutical compositions for the treatment of neoplastic disorders
GB0007193D0 (en) Treatment of movrmrnt disorders
HUP0401023A3 (en) Use of flibanserin in the treatment of sexual disorders
IL157593A0 (en) Carbamate compounds for use in the treatment of pain
GB0316026D0 (en) Compositions containing gangliosides for use in the treatment of skin disorders
HUP0104963A3 (en) Compositions for the treatment of skin diseases
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL140588A0 (en) Therapeutic composition based on flavonoids intended to be used in the treatment of tumours by cytotoxic agents
HUP0204391A3 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
HUP0301553A3 (en) Pharmaceutical compositions and their use for treating neurological disorders
GB2354944B (en) Skin treatment compositions
EP1539100A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
IL150527A0 (en) Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
AU4838301A (en) Treatment of disorders relating to the serotonergic system
EP1315499A4 (en) COMPOSITIONS AND METHODS OF TREATING ANORCAL DISEASES
GB0106316D0 (en) Apparatus for use in the treatment of hair
GB9904252D0 (en) Composition for the treatment of pain
EP1440163A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF PAIN DISEASES USING 46566
GB9822401D0 (en) Device for use in treatment of hair
AU2002358267A8 (en) Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
EP1517912A4 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN AND PAIN DISEASES USING GENES 577, 20739 OR 57145